A Genome-Wide Association Study on Obesity and Obesity- Related Traits

[1]  H. Makhlouf,et al.  Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality , 2011, Hepatology.

[2]  H. Cortez‐Pinto,et al.  Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease , 2011, Diabetologia.

[3]  D. Goulis,et al.  Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. , 2011, Metabolism: clinical and experimental.

[4]  K. Eckardt,et al.  Obesity-associated insulin resistance in skeletal muscle: Role of lipid accumulation and physical inactivity , 2011, Reviews in Endocrine and Metabolic Disorders.

[5]  F. Toledo,et al.  Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide , 2011, Diabetologia.

[6]  Chris Day,et al.  A position statement on NAFLD/NASH based on the EASL 2009 special conference. , 2010, Journal of hepatology.

[7]  J. Duarte,et al.  Lifelong physical activity modulation of the skeletal muscle mitochondrial proteome in mice. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[8]  K. Petersen,et al.  Lipid-induced insulin resistance: unravelling the mechanism , 2010, The Lancet.

[9]  M. Tarnopolsky,et al.  Aberrant Mitochondrial Homeostasis in the Skeletal Muscle of Sedentary Older Adults , 2010, PloS one.

[10]  J. Kountouras,et al.  The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease , 2010, Diabetes, obesity & metabolism.

[11]  R. DeFronzo,et al.  Pathogenesis of Insulin Resistance in Skeletal Muscle , 2010, Journal of biomedicine & biotechnology.

[12]  S. Menini,et al.  Increased tumor necrosis factor α–converting enzyme activity induces insulin resistance and hepatosteatosis in mice , 2010, Hepatology.

[13]  S. Toda,et al.  Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease , 2010, Journal of Gastroenterology.

[14]  G. Heigenhauser,et al.  Skeletal muscle lipogenic protein expression is not different between lean and obese individuals: a potential factor in ceramide accumulation. , 2009, The Journal of clinical endocrinology and metabolism.

[15]  S. Caldwell,et al.  Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. , 2009, Journal of hepatology.

[16]  R. DeFronzo,et al.  Impaired regulation of the TNF-α converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans , 2009, Diabetologia.

[17]  S. Menini,et al.  Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. , 2009, Gastroenterology.

[18]  A. Bonen,et al.  Regulation of skeletal muscle mitochondrial fatty acid metabolism in lean and obese individuals. , 2009, The American journal of clinical nutrition.

[19]  A. Bonen,et al.  PGC-1alpha-mediated regulation of gene expression and metabolism: implications for nutrition and exercise prescriptions. , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[20]  N. Turner,et al.  Muscle insulin resistance: A case of fat overconsumption, not mitochondrial dysfunction , 2008, Proceedings of the National Academy of Sciences.

[21]  Dong-Ho Han,et al.  High-fat diets cause insulin resistance despite an increase in muscle mitochondria , 2008, Proceedings of the National Academy of Sciences.

[22]  V. Schrauwen-Hinderling,et al.  Lipid accumulation in non-adipose tissue and lipotoxicity , 2008, Physiology & Behavior.

[23]  N. Turner,et al.  Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle , 2007, Diabetes.

[24]  Yiying Zhang,et al.  Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. , 2007, The Journal of clinical investigation.

[25]  J. Hawley,et al.  Mitochondrial function: use it or lose it , 2007, Diabetologia.

[26]  Y. Boirie,et al.  Chronological Approach of Diet‐induced Alterations in Muscle Mitochondrial Functions in Rats , 2007, Obesity.

[27]  M. Holmqvist,et al.  Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.

[28]  H. Cortez‐Pinto,et al.  Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis , 2006, European journal of gastroenterology & hepatology.

[29]  G. Marchesini,et al.  Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. , 2005, The Journal of clinical endocrinology and metabolism.

[30]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[31]  P. Ritz,et al.  Muscle fat oxidative capacity is not impaired by age but by physical inactivity: association with insulin sensitivity , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[33]  R. DeFronzo,et al.  Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. , 2004, Diabetes.

[34]  S. Genuth.  Lowering the criterion for impaired fasting glucose is in order. , 2003, Diabetes care.

[35]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[36]  F. Schick,et al.  Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. , 2003, The Journal of clinical endocrinology and metabolism.

[37]  G. Shulman,et al.  Skeletal muscle lipid metabolism with obesity. , 2003, American journal of physiology. Endocrinology and metabolism.

[38]  A. Herling,et al.  Intramyocellular Lipid and Insulin Resistance a Longitudinal in Vivo H-spectroscopic Study in Zucker Diabetic Fatty Rats , 2022 .

[39]  G. Shulman,et al.  Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.

[40]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.

[41]  P. Scifo,et al.  Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation. , 2002, American journal of physiology. Endocrinology and metabolism.

[42]  K. Petersen,et al.  Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. , 2002, Diabetes.

[43]  F. Schick,et al.  Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. , 2001, Diabetes.

[44]  I. Batty,et al.  Ceramide impairs the insulin-dependent membrane recruitment of Protein Kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells , 2001, Diabetologia.

[45]  G. Dohm,et al.  Lipid oxidation is reduced in obese human skeletal muscle. , 2000, American journal of physiology. Endocrinology and metabolism.

[46]  G. Cooney,et al.  Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. , 2000, American journal of physiology. Endocrinology and metabolism.

[47]  Simon C Watkins,et al.  Intramuscular lipid content is increased in obesity and decreased by weight loss. , 2000, Metabolism: clinical and experimental.

[48]  C. Kahn,et al.  Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. , 2000, The Journal of clinical investigation.

[49]  A. Goldberg,et al.  Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men , 1996 .